Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Abbreviating DAPT reduces the risk of bleeding
Nature Reviews Cardiology  (IF32.419),  Pub Date : 2021-09-10, DOI: 10.1038/s41569-021-00619-z
Gregory B. Lim

Data from the MASTER DAPT trial indicate that the duration of dual antiplatelet therapy can be abbreviated in patients at high risk of bleeding undergoing implantation of a drug-eluting stent, resulting in a reduction in bleeding risk without an increase in ischaemic events.